Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma-论文-万方医学网

首页> > Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

导出原文传递

翻译打印收藏纠错

第一作者： Uchimoto, Taizo

作者： Uchimoto, Taizo ^[1] ; Nakamura, Ko ^[2] ; Komura, Kazumasa ^[3] ; Fukuokaya, Wataru ^[4] ; Yano, Yusuke ; Nishimura, Kazuki ; Kinoshita, Shoko ; Nishio, Kyosuke ; Fukushima, Tatsuo ; Nakamori, Keita ; Matsunaga, Tomohisa ; Tsutsumi, Takeshi ; Tsujino, Takuya ; Taniguchi, Kohei ; Tanaka, Tomohito ; Uehara, Hirofumi ; Takahara, Kiyoshi ; Inamoto, Teruo ; Kimura, Takahiro ; Egawa, Shin ; Azuma, Haruhito

作者单位： Dept Urol,Osaka Med & Pharmaceut Univ ^[1] Jikei University,Jikei Univ ^[2] Translat Res Program,Osaka Med & Pharmaceut Univ ^[3] Sch Med,Fujita Hlth Univ ^[4]

关键词 Pembrolizumab Overall survival Urothelial carcinoma Prognostic factor Objective response rate Neutrophil - lymphocyte ratio ONCOLOGIC OUTCOMES CRITERIA

发布时间 2024-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

相似文献

同项目论文

相关期刊

检索历史 清除

Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma

相似文献

同项目论文

相关期刊

检索历史清除